Pharma firms pile up add-on patents to keep drug prices high
Add-on patents have extended drug patent periods from two years to over six, helping pharmaceutical companies maintain high prices.
This story has stopped developing; this page is its permanent record. More from that day
Sources
Every article we clustered into this story. Headlines link to the publisher.